Treatment of central nervous system diseases by antibodies against glatiramer acetate
Details for Australian Patent Application No. 2001272956 (hide)
International Classifications
Event Publications
21 December 2006 Application Accepted
Published as AU-B-2001272956
25 January 2007 Corrigenda
Applications Accepted - Name Index Under the name Teva Pharmaceutical Industries Ltd., Application No. 2001272956, under INID (72), correct the co-inventor to Rodriguez, Moses
19 April 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser